<DOC>
	<DOCNO>NCT00145353</DOCNO>
	<brief_summary>The main purpose study investigate reason reduce number hypoglycaemic attack type 1 diabetic patient , period time , use Insulin Aspart meals together NPH insulin morning evening , , another period time , use human fast-working insulin meal NPH insulin morning evening , patient period simultaneously take extra insulin meal high blood glucose value find meal .</brief_summary>
	<brief_title>Insulin NovoRapid Versus Actrapid Treatment Type 1 Diabetic Patients During Daily Adjustment Insulin Dose</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<criteria>Type 1 diabetes mellitus treat insulin four time daily ( basal bolus treatment ) least three month screen . AGe : 1860 year BMI : 1827.5 No nefro neuropathy ; i.e . Screatinin 120 Î¼mol/l normal monofilament examination Written inform consent Pregnant woman patient plan become pregnant investigation period Reduced eyesight ; i.e . visus &gt; 0.3 evaluate late eye exam . Patient lack ability sen insulin sensitivity Serious rival disease , i.e . heart disease , severe liver lung impairment , severe psychiatric disease . Suspicion abuse noncompliance Participation another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>type 1 diabetes mellitus</keyword>
	<keyword>hypoglycaemia</keyword>
	<keyword>insulin profile</keyword>
	<keyword>growth hormone</keyword>
	<keyword>cortisol</keyword>
	<keyword>glucagon</keyword>
</DOC>